Drug Shortage Report for SANDOZ TAMSULOSIN CR
Report ID | 192570 |
Drug Identification Number | 02340208 |
Brand name | SANDOZ TAMSULOSIN CR |
Common or Proper name | TAMSULOSIN CR |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | TAMSULOSIN HYDROCHLORIDE |
Strength(s) | 0.4MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100PRT |
ATC code | G04CA |
ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2023-05-15 |
Estimated end date | 2023-05-26 |
Actual end date | 2023-05-22 |
Shortage status | Resolved |
Updated date | 2023-05-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2023-05-25 | French | Compare |
v3 | 2023-05-25 | English | Compare |
v2 | 2023-05-15 | French | Compare |
v1 | 2023-05-15 | English | Compare |
Showing 1 to 4 of 4